Research
Research Highlights :Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease.
Dimitris Beis and his colleagues published a paper in Human Molecular Genetics in April 2016.
Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease.
Malissovas N, Griffin LB, Antonellis A, Beis D.
Hum Mol Genet. 2016 Apr 15;25(8):1528-42. doi: 10.1093/hmg/ddw031. Epub 2016 Feb 7.
- HOME |
- BRFAA |
- RESEARCH |
- RESEARCH SUPPORT |
- NEWS & INFORMATION |
- SPECIALIZED HEALTH SERVICES
- CONTACT |
- POLICIES
Copyright © 2024 - All rights reserved
BIOMEDICAL RESEARCH FOUNDATION ACADEMY OF ATHENS4 Soranou Ephessiou St., 115 27 Athens, Greece
Tel: +30 210 6597000 | Fax: +30 210 6597545